Hyundai Motor and Kia Motors are recalling electric vehicles in the United States. The urgent announcement was made on Thursday, March 21. The South Korean automakers issued a recall for a combined 147,110 units.
Cause of the Recall
Hyundai Motor and its Kia Motors subsidiary said some electric vehicle models should be repaired due to the increased crash risk. The companies are pointing to issues with charging as the main reason for the recall.
According to NBC Washington, the U.S. National Highway Traffic Safety Administration (NHTSA) revealed that Hyundai Motor must recall 98,878 units while there are 48,232 affected Kia cars. The federal auto regulator said a glitch in these EV models may cause problems with charging.
The NHTSA explained that the Integrated Charging Control unit of some Hyundai and Kia Motors EVs may become damaged and stop charging; thus, drivers may experience sudden loss of power when driving, and the risk of accidents is heightened. The said control unit is responsible for charging the vehicle’s 12-volt backup battery.
Recalled EV Models
The Daily Mail reported that Hyundai Motor is recalling some batches of its IONIQ 5 and IONIQ 6 EVs and some of its luxury brand, Genesis, models. For Kia Motors, it is recalling some of its EV6 electric vehicles.
Authorized dealers of Hyundai and Kia EVs may have to update or replace the charging control unit of the vehicles. The replacement will be free for all the affected cars and SUVs. In any case, as posted by the NHTSA, the impacted electric cars are the 2023-2024 Genesis GV60, 2023-2024 Genesis GV70, 2023-2024 Genesis GV80; 2022, 2023, and 2024 Hyundai Ioniq 5, 2023-2024 Hyundai Ioniq 6; and 2022, 2023 and 2024 Kia EV6.
Photo by: Pablo Martinez/Unsplash


California's AI Executive Order Pushes Responsible Tech Use in State Contracts
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Apple Turns 50: From Garage Startup to AI Crossroads
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Rubio Directs U.S. Diplomats to Use X and Military Psyops to Counter Foreign Propaganda
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round 



